Correlation Between Pyridam Farma and Merck Tbk

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pyridam Farma and Merck Tbk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pyridam Farma and Merck Tbk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pyridam Farma Tbk and Merck Tbk, you can compare the effects of market volatilities on Pyridam Farma and Merck Tbk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pyridam Farma with a short position of Merck Tbk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pyridam Farma and Merck Tbk.

Diversification Opportunities for Pyridam Farma and Merck Tbk

-0.7
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pyridam and Merck is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Pyridam Farma Tbk and Merck Tbk in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merck Tbk and Pyridam Farma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pyridam Farma Tbk are associated (or correlated) with Merck Tbk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merck Tbk has no effect on the direction of Pyridam Farma i.e., Pyridam Farma and Merck Tbk go up and down completely randomly.

Pair Corralation between Pyridam Farma and Merck Tbk

Assuming the 90 days trading horizon Pyridam Farma Tbk is expected to generate 7.82 times more return on investment than Merck Tbk. However, Pyridam Farma is 7.82 times more volatile than Merck Tbk. It trades about 0.0 of its potential returns per unit of risk. Merck Tbk is currently generating about -0.38 per unit of risk. If you would invest  27,400  in Pyridam Farma Tbk on August 27, 2024 and sell it today you would lose (1,000.00) from holding Pyridam Farma Tbk or give up 3.65% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pyridam Farma Tbk  vs.  Merck Tbk

 Performance 
       Timeline  
Pyridam Farma Tbk 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Pyridam Farma Tbk are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting forward-looking signals, Pyridam Farma disclosed solid returns over the last few months and may actually be approaching a breakup point.
Merck Tbk 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck Tbk has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's forward-looking signals remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Pyridam Farma and Merck Tbk Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pyridam Farma and Merck Tbk

The main advantage of trading using opposite Pyridam Farma and Merck Tbk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pyridam Farma position performs unexpectedly, Merck Tbk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merck Tbk will offset losses from the drop in Merck Tbk's long position.
The idea behind Pyridam Farma Tbk and Merck Tbk pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes